Annual report [Section 13 and 15(d), not S-K Item 405]

Summary of Stock Options Activity (Details)

v3.25.1
Summary of Stock Options Activity (Details) - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]    
Number of Shares, Beginning Balance 139,840  
Weighted Average Exercise Price, Beginning Balance $ 46.09  
Weighted Average Grant Date Fair Value, Beginning $ 42.34  
Weighted Average Remaining Contractual Term (Years), Beginning   8 years 2 months 1 day
Aggregate Intrinsic Value, Beginning Balance  
Number of Shares, Granted  
Weighted Average Exercise Price, Granted  
Weighted Average Grant Date Fair Value, Granted  
Number of Shares, Exercised  
Weighted Average Exercise Price, Exercised  
Weighted Average Grant Date Fair Value, Exercised  
Number of Shares, Forfeited (80,002)  
Weighted Average Exercise Price, Forfeited $ 43.89  
Weighted Average Grant Date Fair Value, Forfeited $ 39.62  
Weighted Average Remaining Contractual Term (Years), Forfeited 6 years 6 months 21 days  
Number of Shares, Canceled/Expired  
Weighted Average Exercise Price, Canceled/Expired  
Weighted Average Grant Date Fair Value, Canceled/Expired  
Number of Shares, Ending Balance 59,838 139,840
Weighted Average Exercise Price, Ending Balance $ 49.03 $ 46.09
Weighted Average Grant Date Fair Value, Ending $ 45.97 $ 42.34
Weighted Average Remaining Contractual Term (Years), Ending 7 years 11 months 23 days  
Aggregate Intrinsic Value, Ending Balance
Number of Shares, Exercisable 45,226  
Weighted Average Exercise Price, Exercisable $ 48.78  
Weighted Average Grant Date Fair Value, Exercisable $ 45.60  
Weighted Average Remaining Contractual Term (Years), Exercisable 7 years 10 months 2 days  
Aggregate Intrinsic Value, Exercisable